Recent years have exposed the vulnerabilities of global supply chains in the pharmaceutical industry. Disruptions overseas can cause delays, shortages, and even impact patient care.
In response, a movement known as "onshoring" is gaining momentum. This trend involves pharmaceutical and biotech companies bringing manufacturing and production processes back to North America, partnering with local Contract Research Organizations (CROs) or Contract Development and Manufacturing Organizations (CDMOs).
This shift towards North American CROs/CDMOs offers a multitude of benefits, fostering a more secure, efficient, and collaborative environment for drug development. In this blog post, we’ll take a closer look at the advantages of partnering with a North American CRO/CDMO.
One of the primary benefits of partnering with a North American CRO/CDMO is the enhanced security of supply. By choosing a domestic or regional partner, pharmaceutical and biotech companies can avoid the disruptions often associated with international supply chains.
This reliable, local source for important chemicals ensures a more stable and predictable production process, reducing the risk of delays or shortages that can impact product availability and patient care.
Leading North American CROs/CDMOs are at the forefront of innovation, investing heavily in state-of-the-art facilities and highly skilled personnel.
GL CHEMTEC’s facilities in Toronto, for example, allow us to deliver exceptional solutions to our clients, including:
This commitment to innovation provides our clients with access to advanced capabilities and expert knowledge, accelerating drug development and improving product quality.
Real-time collaboration is a significant advantage when working with a North American CRO/CDMO. Sharing the same time zone enables prompt responses to inquiries and facilitates immediate problem-solving. This streamlined communication translates to faster decision-making, reduced project timelines, and ultimately, a more productive development process.
The proximity of North American CROs/CDMOs to their clients results in significant logistical benefits. Overnight shipping becomes a viable option, reducing both shipping costs and lead times. This swift delivery capability is particularly crucial for time-sensitive materials or when rapid adjustments to production are necessary.
With a local CRO/CDMO, there's no waiting for overseas shipments that could be delayed by customs or unforeseen circumstances. Overnight delivery ensures a seamless flow of materials, allowing you to maintain an aggressive development timeline.
North America's strong intellectual property (IP) laws provide a vital shield for your innovations. Partnering with a North American CRO/CDMO means your novel compounds and processes are protected throughout the discovery, development and manufacturing stages.
This robust legal framework discourages infringement, ensuring you retain exclusive rights to your intellectual property. This protection is critical, as it allows you to recoup the significant investments made in research and development, ultimately fueling further innovation in the pharmaceutical industry.
Working with a North American CRO/CDMO offers a significant advantage: easy access to your partner's facilities. This proximity goes beyond mere convenience; it fosters a collaborative and transparent environment that builds trust between partners.
By choosing a North American CRO/CDMO, you're not just selecting a service provider; you're gaining a partner whose facilities are readily accessible, allowing for a truly collaborative approach to your projects.
Imagine being able to:
These on-site visits enable you to:
This level of direct interaction leads to a more successful and productive drug development journey.
North American CROs/CDMOs operate under the scrutiny of some of the world's most stringent regulatory bodies, such as the Food and Drug Administration (FDA) in the US and Health Canada. This rigorous oversight provides a significant advantage for pharmaceutical companies. Meticulous quality control measures are implemented throughout the development and manufacturing process, ensuring that products meet the highest safety and efficacy standards.
With a North American CRO/CDMO adhering to these strict regulations, you can navigate the path to regulatory approval with greater confidence, potentially bringing life-changing medications to market faster.
GL CHEMTEC is passionate about your success and committed to solving your most complex chemistry challenges. We offer fast, flexible, cutting-edge solutions to take your medicinal chemistry and early stage small molecule routes to the next level. Our commitment to a collaborative partnership means we scale and adapt precisely to meet your evolving needs.
GL CHEMTEC provides: